Compare Lustrum:KAINOS Laboratories,Inc.:4556

※The values of financial statements might be different from the actual ones. Please confirm the original. [instructions]

Main FunctionHelp Company NameHelp CodeHelp Types of IndustryHelp Market Name Fiscal Year End Year of Listing
Browse U-Chart Add to 'Companies Comparison' list Compare Lustrum Ullet index KAINOS Laboratories,Inc. Go to web site 4556 Medicals 東証スタンダード March 1, 2000 1995.
Analysis u.gifU-Chart AnalysisHelp hikaku.gifAdd to 'Companies Comparison' listHelp u2.gifCompare LustrumHelp mark.gifUllet indexHelp
Accounts Information Balance Sheet Profit and Loss Account Cash Flow Statement
Display

KAINOS Laboratories,Inc. Balance Sheet(B/S)

[Show - Hide] U-Chart:Balance Sheet (B/S)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

KAINOS Laboratories,Inc. Balance Sheet 2025年3月期 KAINOS Laboratories,Inc. Balance Sheet 2024年3月期 KAINOS Laboratories,Inc. Balance Sheet 2023年3月期 KAINOS Laboratories,Inc. Balance Sheet 2022年3月期 KAINOS Laboratories,Inc. Balance Sheet 2021年3月期

[Show - Hide] Balance Sheet (B/S)Help  ※Unit:Millions of Yen

Accounting Date March 31, 2025 March 31, 2024 March 31, 2023 March 31, 2022 March 31, 2021
Cash and Cash Equivalents
(Percent)
3,396up
(38.7%)up
3,174up
(36.9%)down
3,020up
(37.2%)up
2,677up
(35.4%)up
2,244
(32.2%)
Other Current AssetsHelp
(Percent)
2,424down
(27.6%)down
2,520up
(29.3%)up
2,199up
(27.1%)up
2,013up
(26.6%)up
1,814
(26.1%)
Tangible Fixed AssetsHelp
(Percent)
2,515up
(28.6%)down
2,506down
(29.2%)down
2,547up
(31.4%)down
2,535up
(33.5%)down
2,532
(36.4%)
Intangible Fixed AssetHelp
(Percent)
18up
(0.2%)up
17down
(0.2%)down
31down
(0.4%)down
57down
(0.8%)down
98
(1.4%)
Investments and OthersHelp
(Percent)
432up
(4.9%)up
374up
(4.4%)up
319up
(3.9%)up
289up
(3.8%)down
275
(4.0%)
Total AssetsHelp
(Percent)
8,785
(100%)
8,591
(100%)
8,116
(100%)
7,572
(100%)
6,962
(100%)
Total Current LiabilitiesHelp
(Percent)
1,498down
(17.1%)down
2,017up
(23.5%)down
1,977up
(24.4%)up
1,827down
(24.1%)down
1,930
(27.7%)
Total Long-term LiabilitiesHelp
(Percent)
512up
(5.8%)up
307down
(3.6%)down
469down
(5.8%)down
544up
(7.2%)up
373
(5.4%)
Shareholder's EquityHelp
(Percent)
6,775up
(77.1%)up
6,266up
(72.9%)up
5,670up
(69.9%)up
5,200up
(68.7%)up
4,660
(66.9%)
Total LiabilitiesHelp
(Percent)
8,785
(100%)
8,591
(100%)
8,116
(100%)
7,572
(100%)
6,962
(100%)

KAINOS Laboratories,Inc. Profit and Loss Account(P/L)

[表示非表示] U-Chart:Profit and Loss Account (P/L)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

KAINOS Laboratories,Inc. Profit and Loss Account 2025年3月期 KAINOS Laboratories,Inc. Profit and Loss Account 2024年3月期 KAINOS Laboratories,Inc. Profit and Loss Account 2023年3月期 KAINOS Laboratories,Inc. Profit and Loss Account 2022年3月期 KAINOS Laboratories,Inc. Profit and Loss Account 2021年3月期

[Show - Hide] Profit and Loss Account (P/L)Help  ※Unit:Millions of Yen

Accounting Date March 31, 2025 March 31, 2024 March 31, 2023 March 31, 2022 March 31, 2021
Amount of Sales
(Percent)
5,306
(100%)
5,056
(100%)
4,923
(100%)
4,615
(100%)
4,258
(100%)
Total Sales
(Percent)
5,306
(100%)
5,056
(100%)
4,923
(100%)
4,615
(100%)
4,258
(100%)
Cost of SalesHelp
(Percent)
2,631up
(49.6%)up
2,505up
(49.5%)up
2,410up
(48.9%)up
2,207up
(47.8%)up
1,947
(45.7%)
Other Costs and RevenueHelp 2,033up
(38.3%)up
1,914down
(37.8%)down
1,945up
(39.5%)down
1,895up
(41.1%)down
1,894
(44.5%)
Total CostsHelp 4,665 4,418 4,355 4,102 3,840
Net RevenueHelp 2,674up
(50.4%)down
2,552up
(50.5%)down
2,513up
(51.1%)down
2,407up
(52.2%)down
2,311
(54.3%)
Earnings Before TaxHelp 827down
(15.6%)down
930up
(18.4%)up
845up
(17.2%)up
767up
(16.6%)up
613
(14.4%)
Net IncomeHelp 641up
(12.1%)down
638up
(12.6%)up
568up
(11.5%)up
512up
(11.1%)up
417
(9.8%)
当期純利益 641 638 568 512 417

KAINOS Laboratories,Inc. Cash Flow Statement(C/F)

[表示非表示] U-Chart:Cash Flow Statement (C/F)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

KAINOS Laboratories,Inc. Cash Flow Statement 2025年3月期 KAINOS Laboratories,Inc. Cash Flow Statement 2024年3月期 KAINOS Laboratories,Inc. Cash Flow Statement 2023年3月期 KAINOS Laboratories,Inc. Cash Flow Statement 2022年3月期 KAINOS Laboratories,Inc. Cash Flow Statement 2021年3月期

[Show - Hide] Cash Flow Statement (C/F)Help  ※Unit:Millions of Yen

Accounting Date March 31, 2025 March 31, 2024 March 31, 2023 March 31, 2022 March 31, 2021
Operating Cash Flow(OFC)Help
(Percent)
705up
(100.0%)up
431down
(100.0%)down
545down
(100.0%)up
604up
(99.8%)down
591
(100.0%)
Investing Cash Flow(ICF)Help
(Percent)
-71up
(-10.1%)up
-73down
(-16.9%)down
-10up
(-1.9%)up
-141down
(-23.3%)down
-117
(-19.8%)
Financing Cash FlowHelp
(Percent)
-411down
(-58.3%)down
-204down
(-47.3%)down
-191down
(-35.1%)down
-31up
(-5.2%)up
-195
(-32.9%)
Exchange Difference of Cash and Cash EquivalentsHelp
(Percent)
-0down
(0.0%)down
0down
(0.0%)up
0down
(0.0%)down
1up
(0.2%)up
0
(0.0%)
Net Increase and Decrease in Cash and Cash Equivalentsn 222up
(31.6%)down
154down
(35.8%)down
343down
(63.0%)down
433up
(71.5%)up
280
(47.3%)

他社比較Help

Companies in 'Companies Comparison' list

Browsing historyHelp

Your reecently viewed companies

KAINOS Laboratories,Inc.
Media Kobo,Inc.

Company where related level is highHelp

PRISM BioLab
MIZUHO MEDY CO.,LTD.
SEIKAGAKU CORPORATION
R-TECH UENO,LTD.
ASKA Pharmaceutical Co.,Ltd.
Cuorips Inc.
RaQualia Pharma Inc.
KAINOS Laboratories,Inc.
FunPep Company Limited
TAISHO PHARMACEUTICAL HOLDINGS CO., LTD.